New Mountain Capital Makes Majority Investment in Covaris

January 13, 2022

New Mountain Capital has made a majority investment in Covaris, a Woburn, Massachusetts-based manufacturer of sample preparation instruments, consumables and reagents for genomics and proteomics. Founder Jim Laugharn will remain CEO and Chris O'Connell will serve as Executive Chairman as New Mountain partners with Covaris to accelerate growth and expand the company's sample-prep capabilities.

Targets
Covaris, Inc.
Industry
Medical Devices
Location
Massachusetts, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.